The SEC has kept Nasdaq's application to list Bitcoin options on hold while simultaneously granting a review of CME's Bitcoin options contracts. CME is arguing its contracts qualify as commodity option swaps falling exclusively under CFTC jurisdiction, not the SEC's. The parallel tracks create a split regulatory review with potentially divergent outcomes for exchange-listed BTC derivatives.
For Armada's crypto-repo desk, BTC options are a primary hedging tool for institutional counterparties managing collateral price risk on repo transactions. If CME obtains CFTC-only classification while Nasdaq's SEC-regulated product remains delayed, the derivatives liquidity available to hedge funds and market makers for BTC exposure could remain concentrated and potentially thinner than needed. This affects the risk management calculus of counterparties and may influence their appetite for BTC-collateralized repo.